| |
Argomenti e Notizie sull'Osteoporosi con raccolte bibliografiche su
|
a cura del Dott. C.Tarozzi Bologna
|
|
|
|
Rassegna -
Alimenti e Calcio -
Questionari -
T-Score -
Valore di un Test -
Calcolatori -
Contatti -
Digitalia -
Radioactivity |
| Ricerca nell'archivio di questo sito...
?
|
| Nuova bibliografia selezionata fino al mese di maggio 2012 |
Ordina per Autore -
Titolo -
Rivista |
|
|
righe 92
Lee YY, Yang CH, Chen CH, Hwang JS.
Alopecia associated with strontium ranelate use in a 62-year-old woman.
Osteoporos Int. 2012 Apr 12. [Epub ahead of print]
Daniel SK, Lansang MC, Okun MS.
Bone mineral density (BMD) in male patients with Parkinson's disease.
Int J Neurosci. 2012 Apr 18. [Epub ahead of print]
Uzkeser H, Yildirim K, Aktan B, Karatay S, Kaynar H, Araz O, Kilic K.
Bone mineral density in patients with obstructive sleep apnea syndrome.
Sleep Breath. 2012 Apr 2. [Epub ahead of print]
Bolognese MA, Teglbjærg CS, Zanchetta JR, Lippuner K, McClung MR, Brandi ML, Høiseth A, Lakatos P, Moffett AH, Lorenc RS, Wang A, Libanati C.
Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study.
J Clin Densitom. 2012 Apr 19. [Epub ahead of print]
Donaldson M, Palermo L, Ensrud K, Hochberg M, Schousboe J, Cummings S.
Effect of alendronate for reducing fracture by FRAX score and femoral neck BMD: The fracture intervention trial.
J Bone Miner Res. 2012 Apr 10. doi: 10.1002/jbmr.1625. [Epub ahead of print]
Gomes-Filho IS, Oliveira TJ, Passos JS, Cerqueira ED, Da Cruz SS, Barreto ML, Coelho JM, Trindade SC, Santos CA, Sarmento VA.
Effect of osteoporosis on periodontal therapy among post-menopausal women.
Gerodontology. 2012 Mar 16. doi: 10.1111/j.1741-2358.2012.00643.x. [Epub ahead of print]
Briot K, Benhamou CL, Roux C.
Hip cortical thickness assessment in postmenopausal women with osteoporosis and strontium ranelate effect on hip geometry.
J Clin Densitom. 2012 Apr-Jun;15(2):176-85. Epub 2012 Feb 9.
|
Krmar M, Ganezer K.
How to improve x-ray scattering techniques to quantify bone mineral density using spectroscopy.
Med Phys. 2012 Apr;39(4):1831-45.
Goldhahn J, Féron JM, Kanis J, Papapoulos S, Reginster JY, Rizzoli R, Dere W, Mitlak B, Tsouderos Y, Boonen S.
Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper.
Calcif Tissue Int. 2012 May;90(5):343-53. Epub 2012 Mar 28.
Luna-Cabrera F, Justicia-Rull EA, Caricol-Pérez MP, Soler-Vizán E, Mesa-López CM, Ruiz-Ruiz MA, De La Torre-López LE.
Incidence of hypercalcemia, hypercalciuria and related factors in patients treated with recombinant human parathyroid hormone (1-84).
Minerva Med. 2012 Apr;103(2):103-10.
Avdagić SC, Barić IC, Keser I, Rumbak I, Satalić Z.
Influence of Heredity and Environment on Peak Bone Density: A Review of Studies in Croatia.
Arh Hig Rada Toksikol. 2012 Apr 1;63(0):11-16.
Chiang CH, Huang CC, Chan WL, Huang PH, Chen TJ, Chung CM, Lin SJ, Chen JW, Leu HB.
Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study.
J Bone Miner Res. 2012 Apr 24. doi: 10.1002/jbmr.1645. [Epub ahead of print]
Diniz-Freitas M, LĂłpez-CedrĂşn JL, Fernández-Sanromán J, GarcĂa-GarcĂa A, Fernández-Feijoo J, Diz-Dios P.
Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain.
Med Oral Patol Oral Cir Bucal. 2012 May 1. [Epub ahead of print]
Ziller V, Kostev K, Kyvernitakis I, Boeckhoff J, Hadji P.
Persistence and compliance of medications used in the treatment of osteoporosis analysis using a large scale, representative, longitudinal German database.
Int J Clin Pharmacol Ther. 2012 May;50(5):315-22.
|
Dempster DW, Lambing CL, Kostenuik PJ, Grauer A.
Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
Clin Ther. 2012 Mar;34(3):521-36.
Kim KH, Lee CM, Park SM, Cho B, Chang Y, Park SG, Lee K.
Secondhand smoke exposure and osteoporosis in never-smoking postmenopausal women: the Fourth Korea National Health and Nutrition Examination Survey.
Osteoporos Int. 2012 Apr 25. [Epub ahead of print]
Boivin G, Doublier A, Farlay D.
Strontium ranelate - a promising therapeutic principle in osteoporosis.
J Trace Elem Med Biol. 2012 May 5. [Epub ahead of print]
Jiang E, Wang Z, Meng Q, Li S, Wang F, Shao G, Zhang L.
Study on Bone Density at Various Skeletal Sites for the Diagnosis of Primary Osteoporosis.
Cell Biochem Biophys. 2012 Apr 27. [Epub ahead of print]
Harris KB, Nealy KL, Jackson DJ, Thornton PL.
The Clinical Use of Denosumab for the Management of Low Bone Mineral Density in Postmenopausal Women.
J Pharm Pract. 2012 May 1. [Epub ahead of print]
Siris ES, Boonen S, Mitchell PJ, Bilezikian J, Silverman S.
What's in a name? What constitutes the clinical diagnosis of osteoporosis?
Osteoporos Int. 2012 Apr 28. [Epub ahead of print]
Ooi HL, Briody J, McQuade M, Munns CF.
Zoledronic acid improves bone mineral density in paediatric spinal cord injury.
J Bone Miner Res. 2012 Mar 21. doi: 10.1002/jbmr.1598. [Epub ahead of print]
|
|
Modificato il 9-5-2012 |
http://www.tarozzi.net
|